Back to Supplement Finder

N-Acetyl Semax Amidate X 20mg

Sold by FMI Health

INR 8,222.00

View at FMI Health
Store
fmihealth.com
Brand
Biolongevity Labs
Product type
Peptides
Collected
2026-11-20

From the retailer

Retailer description retrieved 2026-11-20. Claims are the retailer’s, not independently verified.

Description--N‑Acetyl Semax Amidate is a stabilized synthetic heptapeptide derived from the ACTH(4‑7) fragment, structurally defined as Ac‑Met‑Glu‑His‑Phe‑Pro‑Gly‑Pro‑NH₂. It incorporates N‑terminal acetylation and C‑terminal amidation, modifications that enhance resistance to enzymatic degradation and extend biological activity. These structural adaptations increase peptide stability, prolong half‑life (approximately 30 minutes longer than standard Semax), and improve neuroprotective efficacy.

 

Mechanistic Claims

  • Melanocortin Receptor Modulation: Interacts with MC₄ and MC₅ receptors, influencing pathways linked to cognition, stress response, and neuroprotection.
  • Neurotransmitter Regulation: Modulates serotonin and dopamine activity, supporting mood and cognitive processes.
  • BDNF Upregulation: Enhances brain‑derived neurotrophic factor (BDNF) expression, promoting neuroplasticity and regeneration.
  • Structural Stability: N‑acetylation and amidation confer resistance to enzymatic breakdown, extending biological activity.
  • Extended Half‑Life: Demonstrates longer duration of action compared to standard Semax formulations.

 

Research Applications

  • Cognitive enhancement and memory studies
  • Neuroprotection and neuroregeneration models
  • Stroke recovery and ischemic injury investigations
  • Neurodegenerative disease research (e.g., Alzheimer’s, Parkinson’s)
  • Stress response and mood regulation studies

 

N‑Acetyl Semax Amidate Research Insights

  • Synthetic heptapeptide engineered for enhanced stability and efficacy.
  • Structural modifications (acetylation and amidation) improve resistance to enzymatic degradation.
  • Demonstrates prolonged half‑life and increased neuroprotective potential compared to standard Semax.
  • Preclinical studies highlight roles in cognitive enhancement, neurotransmitter modulation, and BDNF upregulation.
  • Investigated for therapeutic potential in stroke recovery, neurodegenerative disorders, and stress‑related conditions.


N-Acetyl Semax Research

N-Acetyl Semax is a synthetic heptapeptide demonstrating neuroprotective and cognitive-enhancing properties. Research indicates its potential in preventing amyloid beta aggregation, providing neuroprotection in ischemic conditions, and enhancing learning and memory functions. The peptide achieves these effects through modulation of neurotransmitter systems and regulation of inflammatory responses, while also showing promise in stress response and immune system function.

 

Neuroprotective and Cognitive Effects

Semax has been shown to prevent the formation of amyloid beta (Aβ) complexes with copper ions, which are implicated in Alzheimer’s disease, inhibiting fibrillogenesis and providing protective effects against

 

 

 

 

 

Semax and Alzheimer’s Disease (AD)

Semax is an ACTH-like peptide that has shown the ability to form stable complexes with Cu2+ ions. This property is crucial as it helps prevent the formation of Aβ:Cu2+ complexes, which are implicated in the pathogenesis of AD. Studies have demonstrated that Semax can inhibit fibrillogenesis, particularly the formation of oligomeric species, thereby exhibiting anti-aggregating properties.

 

Research has indicated that Semax can enhance the survival of cholinergic neurons in the basal forebrain, which are known to degenerate in Alzheimer’s dementia. In vitro studies have shown that Semax can increase the survival rate of these neurons by approximately 1.5-1.7 fold and stimulate the activity of choline acetyltransferase, an enzyme critical for acetylcholine

 

 

 

 

 

Immune and Vascular System Modulation

In a study on rat brain focal ischemia, Semax was found to enhance the expression of genes related to the immune system, particularly those encoding immunoglobulins and chemokines, which are crucial for immune cell activity and 

 

In addition to its effects on the immune system, Semax also modulates the vascular system. In ischemic conditions, Semax altered the expression of genes associated with the development and migration of endothelial tissue, smooth muscle cell migration, hematopoiesis, and vasculogenesis.

 

References

  1. Sciacca, M., Naletova, I., Giuffrida, M., & Attanasio, F. (2022). Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. ACS Chemical Neuroscience, 13, 486 – 496. .
  2. Miasoedova, N., Skvortsova, V., Nasonov, E., Zhuravleva, E., Grivennikov, I., Arsen’eva, E., & Sukhanov, I. (1999). [Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 99 5, 15-9..
  3. Kirchev, V. (2023). Cognitive function restoration in rats with chronic brain ischemia using Semax and hopantenic acid comprehensive administration. Journal of Education, Health and Sport. .
  4. Eremin, K., Kudrin, V., Grivennikov, I., Miasoedov, N., & Rayevsky, K. (2004). Effects of Semax on Dopaminergic and Serotoninergic Systems of the Brain. Doklady Biological Sciences, 394, 1-3. .
  5. Dolotov, O., Karpenko, E., Seredenina, T., Inozemtseva, L., Levitskaya, N., Zolotarev, Y., Kamensky, A., Grivennikov, I., Engele, J., & Myasoedov, N. (2006). Semax, an analogue of adrenocorticotropin (4–10), binds specifically and increases levels of brain‐derived neurotrophic factor protein in rat basal forebrain. Journal of Neurochemistry, 97. .
  6. Grivennikov, I., Dolotov, O., Zolotarev, Y., Andreeva, L., Myasoedov, N., Leacher, L., Black, I., & Dreyfus, C. (2008). Effects of behaviorally active ACTH (4-10) analogue – Semax on rat basal forebrain cholinergic neurons.. Restorative neurology and neuroscience, 26 1, 35-43..
  7. Yasenyavskaya, A., Samotrueva, M., Myasoedov, N., & Andreeva, L. (2022). The experimental study of the immunomodulating action of Semax and Selank on the model of „social” stress. European Pharmaceutical Journal, 69, 54 – 60. .
  8. Yasenyavskaya, A., Samotrueva, M., Tsibizova, A., Bashkina, O., Andreeva, L., & Myasoedov, N. (2022). Influence of Semax on the Level of Pro- and Anti-Inflammatory Cytokines in Conditions of “Social” Stress. Current Drug Therapy. .
  9. Glazova, N., Myasoedov, N., Limborska, S., Dergunova, L., Kamensky, A., Andreeva, L., Sebentsova, E., Vilensky, D., Manchenko, D., & Levitskaya, N. (2023). Effects of Semax in the Models of Acute Stress. Российский физиологический журнал им  И  М  Сеченова. .
  10. Samotrueva, M., Yasenyavskaya, A., Murtalieva, V., Myasoedov, N., & Andreeva, L. (2019). INFLUENCE OF SEMAX ON THE INTENSITY OF LIPID PEROXIDATION IN IMMUNOCOMPETENT ORGANS IN THE CONDITIONS OF “SOCIAL” STRESS. , 19, 188-191. .
  11. Medvedeva, E., Dmitrieva, V., Povarova, O., Limborska, S., Skvortsova, V., Myasoedov, N., & Dergunova, L. (2014). The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics, 15, 228 – 228. .


Label--Peptide Information

Property Value
Peptide Sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2
Molecular Formula C37H51N9O10S
Molecular Weight 813.9 g/mol
CAS Number 80714-61-0
PubChem CID 9811102
Synonyms Semax, 80714-61-0, ACTH (4-7), Pro-Gly-Pro-, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro

 

Semax Peptide Structure

Source:


Dosage--This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.